Dr. Gunilla Enblad is a Senior Consultant in Oncology since 2000 and was Head of Department at the Oncology Clinic at Uppsala University Hospital between 2004 and 2012. Enblad is Professor in Oncology at Uppsala University since 2013 and author of 137 scientific publications having in total more than 3000 citations. Gunilla Enblad is a member of the Swedish Hodgkin lymphoma group since many years and acted as their Chairman between 2004 and 2013. Enblad’s current research is focused on CAR T-cell therapy and in 2014 she treated the first patient in Europe with CAR T-cells. She has been the principal investigator for one completed phase I/IIa trial using CD19 CAR T-cells for treatment of refractory or relapsed B-cell malignancies (lymphomas and leukemias) and a completed clinical phase II trial.
